Guidelines for the cardiac sonographer in the performance of contrast echocardiography: Recommendations of the American Society of Echocardiography Council on Cardiac Sonography

Waggoner, Alan D.; Ehler, Donna; Adams, David; Moos, Sally; Rosenbloom, Judy; Gresser, Cris; Pérez, Julio E.; Douglas, Pamela S.

doi:10.1067/mje.2001.113817

Cited by 46 publications

(22 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All studies were performed by a single expert sonographer (WBV) in accordance with the guidelines 18. MCE was performed using a continuous infusion of SonoVue (Bracco, Geneva, Switzerland), at a mean rate of 1.0 ml/min.…”

Section: Methodsmentioning

confidence: 99%

Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography

Soliman

Knaapen

Geleijnse

et al. 2007

Heart

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography

Soliman

Knaapen

Geleijnse

et al. 2007

Heart

View full text Add to dashboard Cite

show abstract

“…However, more than 15% of echocardiographs in the US are suboptimal, i.e. they do not result in definitive diagnosis [5, 6]. UCA can substantially improve the diagnostic abilities of not only echocardiography but also of ultrasound of liver, kidney and other organs [7–9].…”

Section: Introductionmentioning

confidence: 99%

Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery

et al. 2014

View full text Add to dashboard Cite

Micron- to nanometer-sized ultrasound agents, like encapsulated microbubbles and echogenic liposomes, are being developed for diagnostic imaging and ultrasound mediated drug/gene delivery. This review provides an overview of the current state of the art of the mathematical models of the acoustic behavior of ultrasound contrast microbubbles. We also present a review of the in vitro experimental characterization of the acoustic properties of microbubble based contrast agents undertaken in our laboratory. The hierarchical two-pronged approach of modeling contrast agents we developed is demonstrated for a lipid coated (Sonazoid™) and a polymer shelled (poly D-L-lactic acid) contrast microbubbles. The acoustic and drug release properties of the newly developed echogenic liposomes are discussed for their use as simultaneous imaging and drug/gene delivery agents. Although echogenicity is conclusively demonstrated in experiments, its physical mechanisms remain uncertain. Addressing questions raised here will accelerate further development and eventual clinical approval of these novel technologies.

show abstract

“…This simple transition greatly facilitated the use of echocardiography. It also resulted in the need for advanced training and knowledge of cardiac sonographers, who routinely make clinical judgments and modifications of the basic cardiac examination "on the fly" [21][22][23]. This same level of skill and autonomy must become the standard for CMR technologists who need to be proficient at performing a comprehensive CMR examination without the immediate supervision of the physician.…”

Section: Discussionmentioning

confidence: 99%

Bringing MRI to the cardiologist: Can we learn from echocardiography?

Sorrell

2005

Curr Cardiol Rep

View full text Add to dashboard Cite

Cardiac MRI (CMR) is a low-risk, comprehensive diagnostic tool that has many similarities with echocardiography. It is noninvasive, lacks ionizing radiation, and the contrast material used to enhance various images does not have any renal toxicity. Although extremely valuable in the diagnosis of neurologic and musculoskeletal diseases for more than two decades, CMR has only recently become relevant for diagnosing the rapidly beating and constantly mobile heart. Through advances in cardiac gating and high-speed acquisition software, CMR is positioning itself as a critical utensil at the cardiovascular disease banquet. However, like echocardiography, currently celebrating its 50th birthday, CMR is likely to suffer occasional growing pains, along with its share of accomplishments. Therefore, those practicing CMR should learn from the past errors and achievements of echocardiography in an effort to deliver the most rewarding diagnostic instrument imaginable, without having to wait 50 years.

show abstract

Guidelines for the cardiac sonographer in the performance of contrast echocardiography: Recommendations of the American Society of Echocardiography Council on Cardiac Sonography

Cited by 46 publications

References 10 publications

Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography

Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography

Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery

Bringing MRI to the cardiologist: Can we learn from echocardiography?

Contact Info

Product

Resources

About